[{"data":1,"prerenderedAt":46},["ShallowReactive",2],{"q-nurse-109-1-medical-surgical-003":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":22},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":10},"nurse-109-1-內外科護理學-003","nurse-109-1-medical-surgical-003",109,1,3,"有關暫時性缺血發作（transient ischemic attack; TIA）使用藥物治療，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"抗血小板凝集藥物，如：aspirin","降低腦壓藥物，如：mannitol","腦血管擴張劑，如：papaverine","預防血管痙攣劑，如：nimodipine","A",null,[],"本題考點在於暫時性缺血發作(TIA)的藥物治療原則。TIA 為腦部短暫缺血、症狀可完全恢復的警訊,病因多與血小板聚集、微血栓形成有關,治療以抗血小板凝集藥物如 aspirin 預防血栓、降低後續中風風險,故答案為 A。mannitol(B)為滲透性利尿劑,用於降腦壓,非 TIA 常規用藥;papaverine(C)為腦血管擴張劑,並非 TIA 標準治療;nimodipine(D)為鈣離子通道阻斷劑,主要用於預防蜘蛛膜下腔出血後的血管痙攣。考點在於掌握 TIA 以抗血小板治療為核心。",[23,27,31,34,38,42],{"webId":24,"stem":25,"number":10,"year":26,"session":10},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":28,"stem":29,"number":30,"year":26,"session":10},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",2,{"webId":32,"stem":33,"number":11,"year":26,"session":10},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",{"webId":35,"stem":36,"number":37,"year":26,"session":10},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":39,"stem":40,"number":41,"year":26,"session":10},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":43,"stem":44,"number":45,"year":26,"session":10},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840747228]